Bespak

The pMDI landscape is shifting! Over recent years, the Kigali Amendment to the Montreal Protocol has guided the phasedown of HFAs across all industries. However, as regions introduce their own targets, tightening regulations are driving a faster phaseout, including of the propellants used in pMDIs. Our Head of Drug Product Development, Ross Errington, discusses what this means for the pMDI industry in a recent PMPS article. Read the article here: https://lnkd.in/eeyvfFpZ #Bespak #pMDI #inhalationdevices #pmdi #greenpropellants #sustainability #drugdelivery

As the year draws to a close, we take a moment to reflect on the incredible journey we've shared with you. Looking back, it's clear that 2024 has been a year of significant growth and achievement. ✔Collaborations: We've had the privilege of collaborating with some exceptional companies committed to the transition to low GWP propellants. ✔Recognition: We're honoured to have received recognition for our work within the inhalation industry. ✔Community: We’re thankful to have played our part in the development of both our global and local communities to foster growth and deliver a vibrant vision for the future. As we look towards 2025, we're filled with excitement and optimism. We're committed to pushing boundaries, innovating in our field, and delivering even greater value to our customers, partners and stakeholders. A sincere thank you to our incredible clients, partners, and team members for your unwavering support throughout this year. It's your belief, trust and commitment that have propelled us forward. We look forward to achieving even greater things together. #Bespak #YearInReview #ThankYou #LookingForward

Bespak Holmes Chapel this year selected the mid-Cheshire group of foodbanks as their festive charity recipient. A festive raffle was hugely popular and enabled us to donate £1068 to the Middlewich & District Foodbank. Employees were also asked to support via donations of festive-themed food items, and donation boxes located across site were rapidly filled with seasonal packaged produce! On 10 December 2024, Jeremy Tidmarsh welcomed volunteers from the Middlewich & District Foodbank to Holmes Chapel to present our “Charity Cheque”. We are overwhelmed with the generosity from our employees and pleased to help spread a little festive cheer to all those locally who are supported by this very worthy charity! #Bespak #GivingBack #CommunitySupport #MiddlewichFoodbank

Wishing you a joyful holiday season and a prosperous New Year from #Bespak! Thank you for being part of our journey this year – we look forward to an exciting 2025 together.

Sarah Russell, MP for Congleton, recently visited Bespak’s Holmes Chapel site to learn more about our role in the global transition to climate-friendly inhalers.   Sarah met with Bespak CEO Chris Hirst and Holmes Chapel Site Director Jeremy Tidmarsh to discuss Bespak’s future investment in the site, and was able to inspect the new manufacturing equipment in detail with Programme Manager Rachel Hirst and Engineering Project Manager Karen McHugh.   We shared our achievements so far, expanding our footprint with the addition of a new production facility for pMDIs manufactured using the next-generation “greener” propellant, HFO-1234ze. The new facility enables us to service the increasing demand from global pharmaceutical companies developing more sustainable inhalers. Having completed the construction and equipment installation phase, the project now moves into the next phase of pharmaceutical validation to prepare for commercial production in 2025.   “𝗪𝗲 𝗮𝗿𝗲 𝗱𝗿𝗶𝘃𝗲𝗻 𝗯𝘆 𝗼𝘂𝗿 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝘁𝗼 𝗵𝗲𝗹𝗽 𝗺𝗶𝗹𝗹𝗶𝗼𝗻𝘀 𝗼𝗳 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘁𝗼 𝗯𝗿𝗲𝗮𝘁𝗵𝗲 𝗺𝗼𝗿𝗲 𝗲𝗮𝘀𝗶𝗹𝘆, 𝗮𝗻𝗱 𝘄𝗲 𝗮𝗿𝗲 𝗰𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝘁𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻 𝘁𝗼 𝗰𝗹𝗶𝗺𝗮𝘁𝗲-𝗳𝗿𝗶𝗲𝗻𝗱𝗹𝘆 𝗶𝗻𝗵𝗮𝗹𝗲𝗿𝘀. 𝗧𝗵𝗲 𝘁𝗲𝗮𝗺 𝗼𝗳 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗮𝘁 𝗕𝗲𝘀𝗽𝗮𝗸 𝗮𝗿𝗲 𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝘁𝗶𝗿𝗲𝗹𝗲𝘀𝘀𝗹𝘆 𝘁𝗼 𝗯𝗲 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝗽𝗿𝗼𝗱𝘂𝗰𝗲 𝗴𝗿𝗲𝗲𝗻𝗲𝗿 𝗶𝗻𝗵𝗮𝗹𝗲𝗿𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗵𝗼 𝗻𝗲𝗲𝗱 𝘁𝗵𝗲𝗺.” Jeremy Tidmarsh, Bespak Site Director. Read more: https://lnkd.in/eqg_E7Rc #Bespak #Sustainability #InhalationDevices #pMDI #LowGWP #ClimatefriendlyPropellants #DrugDelivery #CDMO

We always look forward to Drug Delivery to the Lungs Conference (DDL), and what an event this year! As proud sponsors of #DDL2024, we at Bespak are thrilled to have been part of such an incredible event - celebrating 35 years of scientific advances in drug delivery to the lungs - the innovation, collaboration, and the future of drug delivery technologies. From thought-provoking presentations to engaging discussions, the energy and passion was obvious throughout the event. Our team thoroughly enjoyed connecting with fellow industry leaders, sharing insights on the journey to support a more sustainable future for our patients, our industry and our planet. A huge thank you to the organisers of DDL - we can’t wait to see how you celebrate 40 years! Until next year!! #Bespak #Sustainability #InhalationDevices #pMDI #LowGWP #ClimatefriendlyPropellants #DrugDelivery #CDMO

Day 2 at DDL!    This morning we had a podium presentation with Sabrina Falloon, Principal Development Engineer at Bespak, where she showcased one of our latest studies on device design tuning and its impact on spray performance.   From optimising spray performance to enhancing pharmaceutical effects, discover how our in-house expertise and cross-functional working is driving solutions that benefit end-users—no matter the formulation or device.   Stop by poster #70 "Comparability of Aerosol Performance of Salbutamol Sulphate Nebuliser Solution Delivered from Resyca® Pulmospray™ and Prefilled Syringe Inhaler (PFSI™) and speak to Lei Mao, PhD our Director of Inhalation Science and Product Development. We are looking forward to seeing everyone at the gala dinner this evening, thank you to the DDL committee for the fabulous event so far!. #DDL2024 #Bespak #Sustainability #InhalationDevices #pMDI #LowGWP #ClimatefriendlyPropellants #DrugDelivery #CDMO

What an incredible start to #DDL2024! Last night we raised a glass to our shared achievements on the journey to support a more sustainable future for our patients, our industry and our planet. Today we joined Koura and DH Industries Limited to discuss the safe handling of Zephex® 152a. If you’d like to attend tomorrow's event in person, register now: https://lnkd.in/eppjvC8P We are looking forward to day 2! #DDL2024 #Bespak #Sustainability #InhalationDevices #pMDI #LowGWP #ClimatefriendlyPropellants #DrugDelivery #CDMO

The Bespak team are really excited to be here in Edinburgh for #DDL2024, celebrating 35 years of DDL and our first as the NEW #Bespak. Come by and see us at booth #189. Later today, Nick Atkinson, will be hosting a presentation with our colleagues from Koura and DH Industries Limited on the safe handling of Zephex® 152a. If you’d like to attend this event in person, register now: https://lnkd.in/eppjvC8P #DDL2024 #Bespak #Sustainability #Pharma #InhalationDevices #pMDI #LowGWP #ClimatefriendlyPropellants #DrugDelivery #CDMO

We are excited to announce an update to our strategic collaboration with OzUK, further enhancing our partnered early-stage pressurised Metered Dose Inhaler (pMDI) product feasibility and development services. This partnership represents a shared commitment to delivering innovative and sustainable solutions for our customers as they transition their pMDI portfolios to low Global Warming Potential (GWP) propellants HFA-152a & HFO-1234ze. This announcement builds on the recent launch of OzUK’s 𝐀𝐓𝐄𝐗-𝐫𝐚𝐭𝐞𝐝 𝐩𝐢𝐥𝐨𝐭 𝐩𝐥𝐚𝐧𝐭, designed to advance the development of low GWP pMDI products using propellant HFA-152a. The facility enables the production of both solution and suspension batches at pilot scale using this new generation propellant. By aligning agile product development and pilot-scale capabilities at OzUK with our GMP clinical-scale capabilities and full-scale production processes at Bespak Holmes Chapel, this collaboration ensures a seamless transition for customers – supporting not just environmental responsibility but also manufacturing excellence. Find out more about how this partnership can support your product development journey here: https://lnkd.in/eYQmHJFZ #DDL2024 #Bespak #Sustainability #Pharma #InhalationDevices #pMDI #LowGWP #ClimatefriendlyPropellants #DrugDelivery #CDMO